Annual Current Liabilities
$9.17 M
-$731.90 K-7.39%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual total current liabilities is currently $9.17 million, with the most recent change of -$731.90 thousand (-7.39%) on 31 December 2022. During the last 3 years, it has fallen by -$4.74 million (-34.07%).ZYNE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$11.46 M
+$1.85 M+19.21%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly total current liabilities is currently $11.46 million, with the most recent change of +$1.85 million (+19.21%) on 30 June 2023.ZYNE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -34.1% | +5.1% |
| 5 y5 years | -5.7% | +23.1% |
ZYNE Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -34.1% | -17.7% |
Zynerba Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $11.46 M(+19.2%) |
| Mar 2023 | - | $9.61 M(+4.8%) |
| Dec 2022 | $9.17 M(-7.4%) | $9.17 M(-2.7%) |
| Sept 2022 | - | $9.43 M(-1.0%) |
| June 2022 | - | $9.53 M(+6.8%) |
| Mar 2022 | - | $8.92 M(-10.0%) |
| Dec 2021 | $9.90 M(-28.8%) | $9.90 M(-9.1%) |
| Sept 2021 | - | $10.90 M(+8.7%) |
| June 2021 | - | $10.03 M(-20.2%) |
| Mar 2021 | - | $12.57 M(-9.7%) |
| Dec 2020 | $13.91 M(+15.4%) | $13.91 M(+31.7%) |
| Sept 2020 | - | $10.57 M(-19.1%) |
| June 2020 | - | $13.06 M(+27.3%) |
| Mar 2020 | - | $10.26 M(-14.9%) |
| Dec 2019 | $12.06 M(+24.0%) | $12.06 M(+29.6%) |
| Sept 2019 | - | $9.30 M(-6.8%) |
| June 2019 | - | $9.99 M(+33.8%) |
| Mar 2019 | - | $7.47 M(-23.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $9.73 M(+30.7%) | $9.73 M(+6.4%) |
| Sept 2018 | - | $9.14 M(-19.0%) |
| June 2018 | - | $11.29 M(+26.7%) |
| Mar 2018 | - | $8.91 M(+19.7%) |
| Dec 2017 | $7.44 M(+6.8%) | $7.44 M(-11.7%) |
| Sept 2017 | - | $8.43 M(+7.2%) |
| June 2017 | - | $7.86 M(+13.3%) |
| Mar 2017 | - | $6.94 M(-0.4%) |
| Dec 2016 | $6.97 M(+76.9%) | $6.97 M(+40.8%) |
| Sept 2016 | - | $4.95 M(-1.7%) |
| June 2016 | - | $5.03 M(+72.7%) |
| Mar 2016 | - | $2.91 M(-26.0%) |
| Dec 2015 | $3.94 M(+25.2%) | $3.94 M(+45.1%) |
| Sept 2015 | - | $2.71 M(-34.3%) |
| June 2015 | - | $4.13 M(+23.7%) |
| Mar 2015 | - | $3.34 M(+6.1%) |
| Dec 2014 | $3.15 M(+101.3%) | $3.15 M |
| Dec 2013 | $1.56 M | - |
FAQ
- What is Zynerba Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ZYNE is $9.17 M
What is the all time high annual current liabilities for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual total current liabilities is $13.91 M
What is Zynerba Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ZYNE is $11.46 M
What is the all time high quarterly current liabilities for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly total current liabilities is $13.91 M